Edition:
India

Dawnrays Pharmaceutical (Holdings) Ltd (2348.HK)

2348.HK on Hong Kong Stock

4.50HKD
9:26am IST
Change (% chg)

HK$0.01 (+0.22%)
Prev Close
HK$4.49
Open
HK$4.50
Day's High
HK$4.54
Day's Low
HK$4.50
Volume
399,000
Avg. Vol
378,049
52-wk High
HK$5.50
52-wk Low
HK$4.14

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 491.06 0.186
FY 2016 Dec '16 405.90 0.168
Jun '16 418.45 0.164
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 1,155.00 1,155.00 1,155.00 1,321.91
Earnings (per share)
Year Ending Dec-18 1 0.42 0.42 0.42 0.57
Sales and Profit Figures in China Yuan Renminbi (CNY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 10.85 31.11 32.91
P/E High - Last 5 Yrs. 20.17 40.94 46.01
P/E Low - Last 5 Yrs. 9.22 23.80 24.39
Beta 0.57 0.90 0.89
Price to Sales (TTM) 3.39 3.98 5.45
Price to Book (MRQ) 1.80 4.84 5.40
Price to Tangible Book (MRQ) 1.81 5.58 6.91
Price to Cash Flow (TTM) 9.02 23.03 23.44
% Owned Institutions -- 1.23 2.17

Dividends

  Company industry sector
Dividend Yield 2.89 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate 9.76 4.33 5.21
Payout Ratio(TTM) 32.27 45.79 43.69

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 17.35 3.67 9.10
Sales (TTM) vs TTM 1 Yr. Ago -1.94 4.71 5.46
Sales - 5 Yr. Growth Rate -5.28 10.04 10.29
EPS (MRQ) vs Qtr. 1 Yr. Ago 13.63 16.65 19.71
EPS (TTM) vs TTM 1 Yr. Ago 1.91 -- --
EPS - 5 Yr. Growth Rate 12.64 9.84 10.75
Capital Spending - 5 Yr. Growth Rate -29.70 15.23 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 5.30 2.11 2.18
Current Ratio (MRQ) 5.83 2.89 2.98
LT Debt to Equity (MRQ) 0.00 9.84 12.13
Total Debt to Equity (MRQ) 0.00 13.84 16.42
Interest Coverage (TTM) -- 36.31 33.18

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 66.51 55.08 54.71
Gross Margin - 5 Yr. Avg. 51.97 52.36 52.40
EBITD Margin (TTM) 43.50 -- --
EBITD - 5 Yr. Avg 33.69 18.50 15.28
Operating Margin (TTM) 39.72 14.38 7.56
Operating Margin - 5 Yr. Avg. 30.13 14.43 10.75
Pre-Tax Margin (TTM) 39.53 14.80 8.34
Pre-Tax Margin - 5 Yr. Avg. 29.85 14.74 11.15
Net Profit Margin (TTM) 31.60 11.07 4.66
Net Profit Margin - 5 Yr. Avg. 23.85 11.08 7.45
Effective Tax Rate (TTM) 20.06 23.18 23.07
Effective Tax Rate - 5 Yr. Avg. 20.12 23.43 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,186,956 950,994,078 858,000,222
Net Income/Employee (TTM) 375,034 111,887,536 100,930,107
Receivable Turnover (TTM) 6.92 5.62 5.77
Inventory Turnover (TTM) 2.15 2.58 3.35
Asset Turnover (TTM) 0.47 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 14.73 11.44 11.00
Return on Assets - 5 Yr. Avg. 12.35 12.97 12.38
Return on Investment (TTM) 17.06 14.89 14.44
Return on Investment - 5 Yr. Avg. 16.66 16.97 16.19
Return on Equity (TTM) 17.56 16.37 16.13
Return on Equity - 5 Yr. Avg. 17.14 18.05 17.53
  1 Year 3 Year 5 Year
Sales % -16.31 -3.42 -5.28
EPS (TTM) % -11.62 20.17 12.64
Dividend % -7.36 -- 9.76
Note: Units in Millions of US Dollars

Performance for Dawnrays Pharmaceutical (Holdings) Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.49%
# of Holders: 38
Total Shares Held: 138,766,661
3 Mo. Net Change: -5,876,523
# New Positions: 0
# Closed Positions: 5
# Increased Positions: 8
# Reduced Positions: 9
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.